Transaction Date | Recipient | Shares | Type | Price | Value |
---|---|---|---|---|---|
9th February 2021 | Joseph C Galante | 4,000 | Open or private sale | $74.03 | $296,120.00 |
26th August 2020 | Joseph C Galante | 225 | Open or private purchase | $3.29 | $740.25 |
21st August 2020 | Joseph C Galante | 375 | Open or private purchase | $3.35 | $1,256.25 |
14th August 2020 | Joseph C Galante | 375 | Open or private purchase | $3.44 | $1,290.00 |
7th August 2020 | Joseph C Galante | 375 | Open or private purchase | $3.42 | $1,282.50 |
31st July 2020 | Joseph C Galante | 375 | Open or private purchase | $3.26 | $1,222.50 |
24th July 2020 | Joseph C Galante | 375 | Open or private purchase | $3.33 | $1,248.75 |
17th July 2020 | Joseph C Galante | 375 | Open or private purchase | $3.29 | $1,233.75 |
10th July 2020 | Joseph C Galante | 375 | Open or private purchase | $3.31 | $1,241.25 |
2nd July 2020 | Joseph C Galante | 300 | Open or private purchase | $3.34 | $1,002.00 |
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 7/10.
Cumberland Pharmaceuticals, Inc. engages in the acquisition, development, and commercialization of prescription products. The company was founded by A. J. Kazimi on January 6, 1999 and is headquartered in Nashville, TN.
23rd February 2021
20th December 2020